Literature DB >> 2778436

Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors.

G L Smith1, S T Howard, Y S Chan.   

Abstract

Nucleotide sequencing of a region of the vaccinia virus genome proximal to the right inverted terminal repeat (ITR) identified two open reading frames (ORFs) encoding proteins of 39K and 40K with amino acid homology to each other, to another vaccinia virus gene near the opposite end of the virus genome and to the superfamily of serine proteinase inhibitors (serpins). Serpins have now been found in poxviruses from the genera orthopox (cowpox and vaccinia viruses), leporipox (myxoma virus) and avipox (fowlpox virus). One of the vaccinia virus serpins identified here (B13R) shares 92% amino acid identity with the serpin from cowpox virus and 46% and 19% identity with vaccinia serpins B24R and K2L, respectively. The amino acid sequence of B13R reported here differs at 11 positions from a recently reported sequence and contains an additional three internal residues. The serpin genes near the right ITR are separated by 8 kb of DNA. Both genes contain early transcriptional termination signals just downstream of the ORFs and are transcribed in a rightward direction towards the end of the genome. Analysis of mRNAs from virus-infected cells demonstrated that all three vaccinia virus serpin genes are transcribed early during infection. The amino acid sequences at the active sites of these serpins suggest that they may inhibit serine proteinases of differing biochemical specificities. The possible functions of these genes are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2778436     DOI: 10.1099/0022-1317-70-9-2333

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  37 in total

1.  An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse.

Authors:  P C Turner; R W Moyer
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

3.  Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus.

Authors:  Shawn S Jackson; Petr Ilyinskii; Valérie Philippon; Linda Gritz; Alicia Gómez Yafal; Kimberly Zinnack; Kristin R Beaudry; Kelledy H Manson; Michelle A Lifton; Marcelo J Kuroda; Norman L Letvin; Gail P Mazzara; Dennis L Panicali
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.

Authors:  R Blasco; B Moss
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

5.  The major antigenic protein of infectious bursal disease virus, VP2, is an apoptotic inducer.

Authors:  A Fernández-Arias; S Martínez; J F Rodríguez
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.

Authors:  Y Xiang; D A Simpson; J Spiegel; A Zhou; R H Silverman; R C Condit
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

7.  Construction of multiple-epitope tag sequence by PCR for sensitive Western blot analysis.

Authors:  K Nakajima; Y Yaoita
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

8.  The inflammasome as a target of modulation by DNA viruses.

Authors:  Lisi Amsler; Daniel Malouli; Victor DeFilippis
Journal:  Future Virol       Date:  2013-04-01       Impact factor: 1.831

9.  Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells.

Authors:  M Li; A A Beg
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

10.  Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus.

Authors:  J A Tine; V Conseil; P Delplace; C De Taisne; D Camus; E Paoletti
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.